Princeton Global Asset Management LLC
Position in CTXR — Citius Pharmaceuticals, Inc.
CIK 1767349
PRINCETON, NJ
Position in CTXR
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$96
-$48 QoQ
Shares Held
160
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 43 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CTXR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Princeton Global Asset Management LLC holds $6,582,922 across 5 Biotechnology names. CTXR ranks #5 (0.0% of the industry book) .
All Filings in CTXR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96 | 160 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $144 | 160 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $124 | 160 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $198 | 160 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $254 | 160 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $238 | 160 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $640 | 160 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,004 | 4,000 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,336 | 4,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,588 | 4,000 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,028 | 4,000 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,736 | 4,000 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $4,800 | 4,000 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $4,680 | 4,000 | Shares | Sole | 2023-04-20 | |
| No filing history on record for this holder in this stock. | ||||||